Calidi Biotherapeutics, Inc. - CLDI
All tracked SEC files for this issuer. Showing up to 200 latest records.
Need parsed ownership details (13D/13G with shares/percent)?
Open ownership details
Form 4 = insider transactions report. Form 144 = notice of proposed sale (not a completed trade confirmation).
Files summary
Total files loaded: 12
Latest filed: May 15, 2026
| Form | Count |
|---|---|
| 8-K | 7 |
| SCHEDULE 13G | 2 |
| SCHEDULE 13D | 2 |
| SCHEDULE 13G/A | 1 |
Latest files
| Filed | Form | Report period | Accession | SEC |
|---|---|---|---|---|
| May 15, 2026 | SCHEDULE 13G | — | 0001172661-26-002136 | View |
| May 14, 2026 | 8-K | May 14, 2026 | 0001493152-26-023094 | View |
| May 08, 2026 | 8-K | May 06, 2026 | 0001493152-26-022024 | View |
| Apr 02, 2026 | 8-K | Mar 29, 2026 | 0001493152-26-014951 | View |
| Mar 31, 2026 | SCHEDULE 13D | — | 0002109116-26-000004 | View |
| Mar 27, 2026 | 8-K | Mar 27, 2026 | 0001493152-26-013236 | View |
| Mar 11, 2026 | 8-K | Mar 05, 2026 | 0001493152-26-009701 | View |
| Mar 09, 2026 | SCHEDULE 13D | — | 0002109116-26-000003 | View |
| Feb 10, 2026 | SCHEDULE 13G/A | — | 0001493152-26-005942 | View |
| Feb 10, 2026 | 8-K | Feb 06, 2026 | 0001493152-26-005840 | View |
| Feb 04, 2026 | SCHEDULE 13G | — | 0002109116-26-000002 | View |
| Jan 29, 2026 | 8-K | Jan 28, 2026 | 0001493152-26-004089 | View |